{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:15:47Z","timestamp":1789611347668,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Growth hormone deficiency (GHD) is the first and most common endocrine complication in pediatric brain tumor survivors (BTS). GHD can occur due to the presence of the tumor itself, surgery, or cranial radiotherapy (CRT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>This study aimed to evaluate management and adherence to current guidelines of the Italian centers engaged in the diagnosis and follow-up of GHD patients with BTS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A multidisciplinary scientific board of pediatric endocrinologists, oncologists and radiologists with neuroimaging expertise discussed and reviewed the main issues relating to the management of GHD in pediatric BTS and developed a survey. The survey included questions relating to organizational aspects, risk factors, diagnosis, definition of stable disease, and treatment. The online survey was sent to an expanded panel of specialists dedicated to the care of pediatric BTS, distributed among the three specialty areas and throughout the country (23 Italian cities and 37 Centers).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The online questionnaire was completed by 86.5% (32 out of 37) of the Centers involved. Most had experience in treating these patients, reporting that they follow more than 50 BTS patients per year. Responses were analyzed descriptively and aggregated by physician specialty. Overall, the results of the survey showed some important controversies in real life adherence to the current guidelines, with discrepancies between endocrinologists and oncologists in the definition of risk factors, diagnostic work-up, decision-making processes and safety. Furthermore, there was no agreement on the neuroimaging definition of stable oncological disease and how to manage growth hormone therapy in patients with residual tumor and GHD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The results of the first Italian national survey on the management of GHD in BTS highlighted the difference in management on some important issues. The time to start and stop rhGH treatment represent areas of major uncertainty. The definition of stable disease remains critical and represents a gap in knowledge that must be addressed within the international guidelines in order to increase height and to improve metabolic and quality of life outcomes in cancer survivors with GHD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.920482","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T08:45:26Z","timestamp":1657788326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Expert Opinion on the Management of Growth Hormone Deficiency in Brain Tumor Survivors: Results From an Italian Survey"],"prefix":"10.3389","volume":"13","author":[{"given":"Natascia","family":"Di Iorgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Morana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovico","family":"D\u2019Incerti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Garr\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Iughetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Matarazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Parpagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pozzobon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacarolina","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata Gabriela","family":"Wasniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Zucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Maghnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073809341709","article-title":"Late Effects of Therapy for Pediatric Brain Tumor Survivors","volume":"24","author":"Turner","year":"2009","journal-title":"J Child Neurol"},{"key":"B2","unstructured":"SEER. Incidence Data 1973-20142014"},{"key":"B3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior Hypopituitarism in Adult Survivors of Childhood Cancers Treated With Cranial Radiotherapy: A Report From the St Jude Lifetime Cohort Study","volume":"33","author":"Chemaitilly","year":"2015","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62564-7","article-title":"Hospital Contacts for Endocrine Disorders in Adult Life After Childhood Cancer in Scandinavia (ALiCCS): A Population-Based Cohort Study","volume":"383","author":"de Fine Licht","year":"2014","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.6545","article-title":"Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study","volume":"34","author":"Mostoufi-Moab","year":"2016","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00834","article-title":"Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes","volume":"104","author":"van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"bnab040","DOI":"10.1210\/endrev\/bnab040","article-title":"Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors","author":"van Iersel","year":"2021","journal-title":"Endocrine Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.45","article-title":"Late Endocrine Effects of Childhood Cancer","volume":"12","author":"Rose","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.9453","article-title":"Growth Hormone Secretion After Conformal Radiation Therapy in Pediatric Patients With Localized Brain Tumors","volume":"29","author":"Merchant","year":"2011","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.5025","article-title":"Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study","volume":"34","author":"Clement","year":"2016","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1976.tb01955.x","article-title":"The Effect of Varying Doses of Cerebral Irradiation on Growth Hormone Production in Childhood","volume":"5","author":"Shalet","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.1492","article-title":"Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors","volume":"36","author":"Vatner","year":"2018","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.01079.x","article-title":"Cranial Radiotherapy of Childhood Brain Tumours: Growth Hormone Deficiency and its Relation to the Biological Effective Dose of Irradiation in a Large Population Based Study","volume":"53","author":"Schmiegelow","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01204","article-title":"Diagnosis of GH Deficiency as a Late Effect of Radiotherapy in Survivors of Childhood Cancers","volume":"103","author":"Sfeir","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.13.5293","article-title":"Endocrine Outcomes for Children With Embryonal Brain Tumors After Risk-Adapted Craniospinal and Conformal Primary-Site Irradiation and High-Dose Chemotherapy With Stem-Cell Rescue on the SJMB-96 Trial","volume":"26","author":"Laughton","year":"2008","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1056\/NEJM199301143280203","article-title":"Hypothalamic-Pituitary Dysfunction After Radiation for Brain Tumors","volume":"328","author":"Constine","year":"1993","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2009.06.004","article-title":"Prevalence and Risk Factors of Radiation-Induced Growth Hormone Deficiency in Childhood Cancer Survivors: A Systematic Review","volume":"35","author":"Mulder","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00804.x","article-title":"Serum IGF-I and IGFBP-3 Concentrations do Not Accurately Predict Growth Hormone Deficiency in Children With Brain Tumours","volume":"51","author":"Weinzimer","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24015","article-title":"The Limited Screening Value of Insulin-Like Growth Factor-I as a Marker for Alterations in Body Composition in Very Long-Term Adult Survivors of Childhood Cancer","volume":"59","author":"Blijdorp","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00525","article-title":"Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency","volume":"10","author":"Patti","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1210\/jc.2002-021094","article-title":"The Usefulness of the Combined Growth Hormone (GH)-Releasing Hormone and Arginine Stimulation Test in the Diagnosis of Radiation-Induced GH Deficiency Is Dependent on the Post-Irradiation Time Interval","volume":"88","author":"Darzy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0304","article-title":"The Utility of the Growth Hormone (GH) Releasing Hormone-Arginine Test for Diagnosing GH Deficiency in Adults With Childhood Acute Lymphoblastic Leukemia Treated With Cranial Irradiation","volume":"90","author":"Bj\u00f6rk","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.2.7235","article-title":"The Impact of Irradiation on Growth Hormone Responsiveness to Provocative Agents Is Stimulus Dependent: Results in 161 Individuals With Radiation Damage to the Somatotropic Axis1","volume":"86","author":"Lissett","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01205","article-title":"GH Therapy in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.18.1401","article-title":"Comparison of One-, Two-, and Three-Dimensional Measurements of Childhood Brain Tumors","volume":"93","author":"Warren","year":"2001","journal-title":"JNCI J Natl Cancer Institute"},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/neuonc\/nox087","article-title":"Response Assessment in Medulloblastoma and Leptomeningeal Seeding Tumors: Recommendations From the Response Assessment in Pediatric Neuro-Oncology Committee","volume":"20","author":"Warren","year":"2018","journal-title":"Neuro Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-016-0507-6","article-title":"Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials","volume":"14","author":"Ellingson","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28293","article-title":"A Multidisciplinary Clinic for Childhood Cancer Survivors: Which Subspecialists Should be Included","volume":"67","author":"Ryan","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.06.004","article-title":"European PanCareFollowUp Recommendations for Surveillance of Late Effects of Childhood, Adolescent, and Young Adult Cancer","volume":"154","author":"van Kalsbeek","year":"2021","journal-title":"Eur J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00438.x","article-title":"Growth Hormone Status in Adults Treated for Acute Lymphoblastic Leukaemia in Childhood","volume":"48","author":"Brennan","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.18.3273","article-title":"Late Effects of Treatment in Survivors of Childhood Acute Myeloid Leukemia","volume":"18","author":"Leung","year":"2000","journal-title":"J Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.142","article-title":"Outcomes of Growth Hormone Replacement Therapy in Survivors of Childhood Acute Lymphoblastic Leukemia","volume":"20","author":"Leung","year":"2002","journal-title":"J Clin Oncol"},{"key":"B34","unstructured":"Nota 39"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1159\/000495760","article-title":"The Predictive Value of Insulin-Like Growth Factor 1 in Irradiation-Dependent Growth Hormone Deficiency in Childhood Cancer Survivors","volume":"90","author":"Cattoni","year":"2018","journal-title":"Hormone Res paediatrics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1159\/000519031","article-title":"Is Gadolinium Contrast Necessary for Pituitary MRI in the Evaluation of Pediatric Short Stature and Growth Hormone Deficiency","volume":"94","author":"Almaghraby","year":"2021","journal-title":"Hormone Res Paediatrics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-018-4165-1","article-title":"Gadolinium-Based Contrast Agents in Children","volume":"48","author":"Rozenfeld","year":"2018","journal-title":"Pediatr Radiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0873","article-title":"GH Safety Workshop Position Paper: A Critical Appraisal of Recombinant Human GH Therapy in Children and Adults","volume":"174","author":"Allen","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01133","article-title":"Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort","volume":"104","author":"Swerdlow","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.745932","article-title":"Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors","volume":"12","author":"Pollock","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.920482\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T08:45:29Z","timestamp":1657788329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.920482\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":40,"alternative-id":["10.3389\/fendo.2022.920482"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.920482","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"article-number":"920482"}}